About MediDash
What it is
MediDash tracks what happens to new drugs and devices after FDA approval: whether Medicare pays for them, and where they are adopted.
How it works
Each time Medicare publishes a payment rule, we turn it into one table. Every company and ticker is checked against public sources before it is shown, and ownership is re-checked every rule cycle. Anything not yet verified is withheld.
When it updates
Twice a year today, with the inpatient rule: proposed in April and final in August. The outpatient rule, proposed in July and final in November, is being added.
Who is behind it
Kuma Holdings LLC
Contact
MediDash is an information service. It is not investment advice.